alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Consent of Independent Auditors
  RegistrationStatementNumber
    
    Form
    
    Description333-05257
    
    Form S-8
    
    1995 Stock Option Plan, as amended, 1996
Directors Stock Option Plan, Stock Option
Agreement entered into, effective January 4,
1995 by and between Sunrise Assisted Living,
Inc. and David W. Faeder333-38430
    
    Form S-8
    
    1996 Non-Incentive Stock Option Plan, as Amended333-26837
    
    Form S-8
    
    1997 Stock Option Plan333-57291
    
    Form S-8
    
    1996 Directors Stock Option Plan, as Amended333-57293
    
    Form S-8
    
    1998 Stock Option Plan333-78313
    
    Form S-8
    
    1999 Stock Option Plan333-38432
    
    Form S-8
    
    2000 Stock Option Plan333-61918
    
    Form S-8
    
    2001 Stock Option Plan333-88570
    
    Form S-8
    
    2002 Stock Option and Restricted Stock Plan333-61914
    
    Form S-8
    
    Employee Stock Purchase Plan333-109228
    
    Form S-8
    
    2003 Stock Option and Restricted Stock Plan333-120738
    
    Form S-8
    
    Employee Stock Purchase Plan
[Federal Register Volume 75, Number 98 (Friday, May 21, 2010)]
[Notices]
[Page 28656]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-12288]


-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Employment and Training Administration

[TA-W-70,981]


Amphenol Printed Circuits, Inc., a Subsidiary of Amphenol 
Corporation, Including On-Site Leased Workers From Technical Needs, 
MicoTech, and CoWorx, Nashua, NH; Amended Certification Regarding 
Eligibility To Apply for Worker Adjustment Assistance

    In accordance with Section 223 of the Trade Act of 1974, as amended 
(``Act''), 19 U.S.C. 2273, the Department of Labor issued a 
Certification of Eligibility to apply for Worker Adjustment Assistance 
on March 5, 2010, applicable to workers at Amphenol Printed Circuits, 
Inc., a subsidiary of Amphenol Corporation, Nashua, New Hampshire. The 
notice was published in the Federal Register April 23, 2010 (75 FR 
21362).
    At the request of the State Agency, the Department reviewed the 
certification for workers of the subject firm. The workers are engaged 
in activities related to the production of rigid commercial products.
    The company reports that workers leased from Technical Needs, 
MicoTech, and CoWorx were employed on-site at the Nashua, New 
Hampshire, location of Amphenol Printed Circuits, Inc., a subsidiary of 
Amphenol Corporation. The Department has determined that these workers 
were sufficiently under the control of the subject firm to be 
considered leased workers.
    Based on these findings, the Department is amending this 
certification to include workers leased from Technical Needs, MicoTech, 
and CoWorx working on site at the Nashua, New Hampshire, location of 
Amphenol Printed Circuits, Inc., a subsidiary of Amphenol Corporation.
    The amended notice applicable to the TA-W-70,981 is hereby issued 
as follows:

    All workers of Amphenol Printed Circuits, Inc., a subsidiary of 
Amphenol Corporation, including on-site leased workers from 
Technical Needs, MicoTech, and CoWorx, Nashua, New Hampshire, who 
became totally or partially separated from employment on or after 
June 1, 2008, through March 5, 2012, and all workers in the group 
threatened with total or partial separation from employment on the 
date of certification through two years from the date of 
certification, are eligible to apply for adjustment assistance under 
Chapter 2 of Title II of the Trade Act of 1974, as amended.

    Signed in Washington, DC, this 12th day of May 2010.
Del Min Amy Chen,
Certifying Officer, Division of Trade Adjustment Assistance.
[FR Doc. 2010-12288 Filed 5-20-10; 8:45 am]
BILLING CODE 4510-FN-P
#### Joseph L. Lazarony and Others, Respondents, v. Pennsylvania Railroad Company, Appellant.

Judgment affirmed, with costs.

All concurred.
II

106TH CONGRESS

2D SESSION S. 2644

To amend title XVIII of the Social Security Act to expand medicare coverage

of certain self-injected biologicals.

IN THE SENATE OF THE UNITED STATES

MAY 25, 2000

Mr. GORTON (for himself, Mrs. MURRAY, Mr. SANTORUM, Ms. MIKULSKI, Mr.

STEVENS, Mr. COCHRAN, and Mr. L. CHAFEE) introduced the following

bill; which was read twice and referred to the Committee on Finance

A BILL

To amend title XVIII of the Social Security Act to expand

medicare coverage of certain self-injected biologicals.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Access to Innovation

5 for Medicare Patients Act of 2000’’.

6 SEC. 2. MEDICARE COVERAGE OF SELF-INJECTED

7 BIOLOGICALS.

8 (a) COVERAGE.—
2

•S 2644 IS

1 (1) IN GENERAL.—Section 1861(s)(2) of the

2 Social Security Act (42 U.S.C. 1395x(s)(2)) is

3 amended—

4 (A) in subparagraph (S), by striking

5 ‘‘and’’ at the end;

6 (B) in subparagraph (T), by inserting

7 ‘‘and’’ after the semicolon at the end; and

8 (C) by inserting after subparagraph (T)

9 the following new subparagraph:

10 ‘‘(U) a self-injected biological (which is ap11 proved by the Food and Drug Administration) that

12 is prescribed as a complete replacement for a drug

13 or biological that would otherwise be described in

14 subparagraph (A) or (B);’’.

15 (2) CONFORMING AMENDMENT.—Subpara16 graphs (A) and (B) of section 1861(s)(2) of the So17 cial Security Act (42 U.S.C. 1395x(s)(2)) are each

18 amended by inserting ‘‘(except as provided in sub19 paragraph (U))’’ after ‘‘biologicals’’.

20 (b) EFFECTIVE DATE.—The amendments made by

21 subsection (a) apply to biologicals furnished on or after

22 January 1, 2001.

Æ
##### 



Exhibit 32.1
 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AND EXCHANGE ACT RULE 13a-14(b)
  (1)
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the Company.
of the Company.
 Date: May 4, 2006
    
    /s/ René J. RobichaudRené J. RobichaudChief Executive OfficerNS Group, Inc.
# Arthur Pue Gorman: A Featured Biography

**

----

Arthur Pue Gorman (1839-1906) represented Maryland in the U.S. Senate from 1881 to 1899 and again from 1903 until his death in 1906. Gorman informally led the Senate Democrats throughout the 1890s and was unanimously elected as the first official chairman of the Senate Democratic Conference on March 6, 1903. His congressional career began in 1852 when he became a page in the House of Representatives. Senator Stephen A. Douglas brought him to the Senate, appointing him as his personal secretary. While still on the Senate staff, Arthur Gorman avidly played baseball in the evenings, becoming president of the National Association of Base Ball Players in 1867. Eventually, the young Gorman advanced to the position of postmaster before leaving Senate employment in 1866. Following ventures in business and a distinguished career in the Maryland state legislature, Gorman became a U.S. senator in 1881. He proved to be a skilled strategist and compromiser, and was instrumental in passing the "McKinley tariff" in 1890 and the "Wilson-Gorman tariff" of 1894. A portrait of Senator Gorman by Louis P. Dietrich is in the Senate’s collection of fine art.

All Featured Biographies

        -  Contact 
        -  Leadership & Officers 
        -  Former Senators 
        -  Qualifications & Terms of Service 
        -  Facts & Milestones 
        -  States 

### Organizational Chart 

This chart shows the relationships among Senate leaders and officers who manage the flow of legislative and administrative business in the Senate.  

### Contact Your Senator 

Can't find your senator's name in the list of Senators?  Perhaps he or she is a member of the U.S. House of Representatives, or a Senator in your State Legislature.

### Biographical Directory 

The Directory provides information about former and current senators.

### Related Art 

Arthur Pue Gorman
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan



### August 29, 2006 Clifford W. Taylor, Chief Justice


### 131159 Michael F. Cavanagh Elizabeth A. Weaver Marilyn Kelly Maura D. Corrigan 

### PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee, Robert P. Young, Jr. Stephen J. Markman, Justices



### v SC: 131159 COA: 268860 Washtenaw CC: 04-002052-FH VICTOR LYNN STEPHENS, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appe al the April 19, 2006 order of the Court of Appeals is considered, and it is DENIED, because we are not persuaded that the question presented should be reviewed by this Court.

p0821 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

August 29, 2006

Clerk
<TABLE> <S> <C>

<ARTICLE>         5
<LEGEND>
This schedule contains summary financial information extracted from the
Consolidated Balance Sheet at June 30, 1999 (Unaudited) and the Consolidated
Statement of Operations for the six months ended June 30, 1999 (Unaudited)
and is qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER>      1,000

<S>                                        <C>
<PERIOD-TYPE>                              6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                           1,469
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 1,577
<PP&E>                                          40,528
<DEPRECIATION>                                  16,704
<TOTAL-ASSETS>                                  26,870
<CURRENT-LIABILITIES>                            1,810
<BONDS>                                         20,556
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                       4,504
<TOTAL-LIABILITY-AND-EQUITY>                    26,870
<SALES>                                              0
<TOTAL-REVENUES>                                 4,036
<CGS>                                                0
<TOTAL-COSTS>                                    1,843
<OTHER-EXPENSES>                                   869
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 851
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       473
<EPS-BASIC>                                    19.36
<EPS-DILUTED>                                    19.36


</TABLE>
<PAGE>   1
                                 EXHIBIT 12.01

               CRESCENT REAL ESTATE EQUITIES LIMITED PARTNERSHIP

               Computation of Ratio of Earnings to Fixed Charges
                             (dollars in thousands)



<TABLE>
<CAPTION>
                                                   For the Year               For the Year          For the Year
                                                      Ended                       Ended                 Ended
                                                 December 31, 1998         December 31, 1997      December 31, 1996
                                                 -----------------         -----------------      -----------------

<S>                                                  <C>                        <C>                     <C>
Pretax Income from Continuing Operations             183,210                    135,024               $ 47,951
Interest Expense                                     152,214                     86,441                 42,926
Amortization of Deferred Financing Costs               6,486                      3,499                  2,812
                                                     -------                    -------               --------
Earnings                                             341,910                    224,964               $ 93,688
                                                     =======                    =======               ========
Interest Expense                                     152,214                     86,441                 42,926
Capitalized Interest                                     575                      2,030                    946
Amortization of Deferred Financing Costs               6,486                      3,499                  2,812
                                                     -------                    -------               --------
Fixed Charges                                        159,275                     91,970               $ 46,684
                                                     =======                    =======               ========
Ratio of Earnings to Fixed Charges                      2.15                       2.45                   2.01
                                                     =======                    =======               ========
</TABLE>
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                              OCT-1-1997
<PERIOD-END>                               SEP-30-1998
<CASH>                                             745
<INT-BEARING-DEPOSITS>                           2,374
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                      4,474
<INVESTMENTS-CARRYING>                           1,680
<INVESTMENTS-MARKET>                             1,693
<LOANS>                                         38,400
<ALLOWANCE>                                         95
<TOTAL-ASSETS>                                  48,871
<DEPOSITS>                                      41,383
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                                495
<LONG-TERM>                                      2,429
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             3
<OTHER-SE>                                       4,561
<TOTAL-LIABILITIES-AND-EQUITY>                  48,871
<INTEREST-LOAN>                                  3,018
<INTEREST-INVEST>                                  394
<INTEREST-OTHER>                                   110
<INTEREST-TOTAL>                                 3,522
<INTEREST-DEPOSIT>                               2,275
<INTEREST-EXPENSE>                               2,388
<INTEREST-INCOME-NET>                            1,134
<LOAN-LOSSES>                                        0
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  1,241
<INCOME-PRETAX>                                    477
<INCOME-PRE-EXTRAORDINARY>                         477
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       289
<EPS-PRIMARY>                                     1.02
<EPS-DILUTED>                                     1.02
<YIELD-ACTUAL>                                    2.42
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                    95
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                   95
<ALLOWANCE-DOMESTIC>                                95
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                             95
        

</TABLE>
Amendment Agreement Company CP IV Coinvestment Initial Carlyle Stockholders Executive
 RECITALS:
  AGREEMENT
  Amendments
  Carlyle Designees Executive Designees Stockholders Designees




---



##### 



Miscellaneous
 Effect of Amendment
 Governing Law
 Interpretation
 Counterparts
 Severability
 Remainder of Page Intentionally Left Blank.




---



##### 



SS&C TECHNOLOGIES HOLDINGS, INC.By:
    
    /s/ Patrick J. PedontiName: Patrick J. Pedonti
Title: Senior Vice President and Chief Financial OfficerCARLYLE PARTNERS IV, L.P.,a Delaware limited partnershipBy: TC Group IV, L.P.,
its General PartnerBy: TC Group IV Managing GP, L.L.C.,
its General PartnerBy: TC Group, L.L.C.,
its Managing MemberBy: TCG Holdings, L.L.C.,
its Managing MemberBy:
    
    /s/ Claudius E. Watts, IVName: Claudius E. Watts, IVTitle: Managing DirectorCP IV COINVESTMENT, L.P.,a Delaware limited partnershipBy: TC Group IV, L.P.,
its General PartnerBy: TC Group IV Managing GP, L.L.C.,
its General PartnerBy: TC Group, L.L.C.,
its Managing MemberBy: TCG Holdings, L.L.C.,
its Managing MemberBy:
    
    Claudius E. Watts, IVName: Claudius E. Watts, IVTitle: Managing DirectorBy:
    
    /s/ William C. StoneWilliam C. Stone
 [Signature Page to Amendment No. 3 to Stockholders Agreement]
Exhibit 10.1


 


AMENDMENT TO BIOSCRIP, INC. 


2008 EQUITY INCENTIVE PLAN


 


This AMENDMENT TO
THE BIOSCRIP, INC. 2008 EQUITY INCENTIVE PLAN (the “Amendment”), is made on the date last
below written by BIOSCRIP, INC., a corporation organized and existing under the laws of the State of Delaware (the “Company”).


 


WHEREAS, the
Company adopted the BioScrip, Inc. 2008 Equity Incentive Plan, originally effective April 28, 2008, and as last amended and restated
effective as of May 8, 2014, as may be further amended (the “Plan”); and


 


WHEREAS, Section
17 of the Plan provides that the Company may amend the Plan from time to time; and


 


WHEREAS, the
Company wishes to amend the Plan to increase the number of shares of the common stock of the Company in the aggregate that may
be subject to awards granted to directors under the Plan.


 


NOW, THEREFORE,
the Plan is amended as follows:


 


		1.	Paragraph (a) of Section 3.1 of the Plan is amended and restated to read as follows:



 


3.1Number
of Shares (a) Subject to adjustment as provided in Section 15, a total of 9,355,000 shares of Stock shall be authorized for
issuance under the Plan (which number shall include the 6,855,000 shares of Stock previously authorized for issuance under the
Plan), all of which may be subject to ISOs, less one (1) share of Stock for every one (1) share of Stock that was subject to an
Option or Stock Appreciation Right granted after December 31, 2007 under the Prior Plan and one and 53/100 (1.53) shares of Stock
for every one (1) share of Stock that was subject to an Award other than an Option or Stock Appreciation Right granted after December
31, 2007 under the Prior Plan. In no event may more than 1,500,000 shares of Stock in the aggregate be subject to Awards granted
to Directors. Any shares of Stock that are subject to Awards of Options or Stock Appreciation Rights shall be counted against this
limit as one (1) share of Stock for every one (1) share of Stock issued. Any shares of Stock that are subject to Awards other than
Options or Stock Appreciation Rights shall be counted against this limit as one and 53/100 (1.53) shares of Stock for every one
(1) share of Stock issued.


 


2.            Except as provided in this Amendment,
no other changes or amendments shall be made to the Plan as previously stated (including all prior amendments) and the remainder
thereof shall remain in full force and effect.


 


IN WITNESS WHEREOF,
the Company has executed this Amendment on this 1 the day of June, 2016.


 





	 	BIOSCRIP, INC.
	 	 	 
	 	By:  	/s/ Kathryn M. Stalmack
EXHIBIT 32.1



CERTIFICATE PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report on Form 10-Q for the three months ended September 30, 2005, of Commercial Federal Corporation as filed with
the Securities and Exchange Commission on the date hereof (the Report), I, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that, to my knowledge:



| | (i) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Commercial Federal Corporation.
| | ---- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                       |  |     |  |                                                     
|---------------------- |  | --- |  | ----------------------------------------------------
|Date: November 9, 2005 |  |     |  |                                                     
|                       |  | By: |  | /s/ William A. Fitzgerald                           
|                       |  |     |  | William A. Fitzgerald                               
|                       |  |     |  | Chairman of the Board and Chief Executive Officer   
|                       |  |    
|                       |  |     |  | /s/ David S. Fisher                                 
|                       |  |     |  | David S. Fisher                                     
|                       |  |     |  | Executive Vice President and Chief Financial Officer